(Total Views: 161)
Posted On: 04/15/2017 5:05:20 PM
Post# of 72443
Re: Loose Lips #32843
If the K-OC trial produces some impressive efficacy data, then everyone is going to talk about K. We shareholders just need to wait a little longer.
The safety profile is so good that the bashers' response is "so is water". It makes me laugh and smile at the same time.
The safety profile is so good that the bashers' response is "so is water". It makes me laugh and smile at the same time.
(1)
(0)
Scroll down for more posts ▼
